Vicore Pharma Holding AB (($DE:6Y4)) announced an update on their ongoing clinical study. Vicore Pharma Holding AB is conducting a clinical study ...

The henna tree is commonly used for making henna dye. Now, a new study suggests that the same pigments that change your skin ...

PAP is a rare lung condition that can be difficult to diagnose because it may mimic many other more common lung diseases,” ...

Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons ...

Scientists uncover a molecular “switch” in lung cells that controls repair vs. defense. Targeting it could boost tissue ...

Researchers uncovered how lung cells decide whether to rebuild tissue or fight infection. This built-in “switch” may be the ...

By cracking a medical mystery, Northwestern Medicine researchers may be on the cusp of discovering new drugs to treat the ...

Despite showing no meaningful benefit on lung function, Arcturus’ mRNA therapy ARCT-032 reduced mucus volume in patients with ...

The investigators hypothesized that AFM might be able to identify unique nanomechanical fingerprints (NMFs) in tissue samples ...

Arcturus stock drops on interim Phase 2 results for ARCT-032, showing promising mucus reduction in cystic fibrosis patients ...

The use of CT scans is moving beyond a simple diagnostic tool for non–cystic fibrosis bronchiectasis to become a practical ...

CHICAGO -- Brensocatib (Brinsupri) appeared to have a disease-modifying effect on structural lung changes in non-cystic ...